|
64
|
254
|
7phxH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - acid-stable sulfotyrosine analogue |
|
6
|
29
|
7phxL |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - acid-stable sulfotyrosine analogue |
|
59
|
258
|
7ac9H |
Thrombin in complex with d-arginine (j77) |
|
2
|
28
|
7ac9L |
Thrombin in complex with d-arginine (j77) |
|
1
|
28
|
6zgoL |
Thrombin in complex with d-phe-pro-2-chlorofuran derivative (13l) |
|
56
|
259
|
6zgoH |
Thrombin in complex with d-phe-pro-2-chlorofuran derivative (13l) |
|
1
|
28
|
6yn3L |
Thrombin in complex with 4-hydroxybenzamide (j89) |
|
56
|
257
|
6yn3H |
Thrombin in complex with 4-hydroxybenzamide (j89) |
|
2
|
28
|
6ympL |
Thrombin in complex with 3-((5-(tert-butyl)isoxazol-3-yl)methyl)oxetan-3-amine (j54) |
|
58
|
258
|
6ympH |
Thrombin in complex with 3-((5-(tert-butyl)isoxazol-3-yl)methyl)oxetan-3-amine (j54) |
|
56
|
257
|
6yb6H |
Thrombin in complex with d-phe-pro-3-chloro-1,3-dihydroxybenzylamide derivative (13c) |
|
1
|
28
|
6yb6L |
Thrombin in complex with d-phe-pro-3-chloro-1,3-dihydroxybenzylamide derivative (13c) |
|
57
|
258
|
6yhgH |
Thrombin in complex with d-phe-pro-m-methoxybenzylamide derivative (16a) |
|
57
|
257
|
6y9hH |
Thrombin in complex with d-phe-pro-m-trifluoromethylbenzylamide derivative (phe2) |
|
1
|
31
|
6yhgL |
Thrombin in complex with d-phe-pro-m-methoxybenzylamide derivative (16a) |
|
1
|
28
|
6y9hL |
Thrombin in complex with d-phe-pro-m-trifluoromethylbenzylamide derivative (phe2) |
|
64
|
259
|
7a0dHHH |
The crystal structure of bovine thrombin in complex with hirudin (c16u/c28u) at 1.6 angstroms resolution |
|
8
|
35
|
7a0fLLL |
The crystal structure of bovine thrombin in complex with hirudin (c22u/c39u) at 2.7 angstroms resolution |
|
8
|
35
|
7a0dLLL |
The crystal structure of bovine thrombin in complex with hirudin (c16u/c28u) at 1.6 angstroms resolution |
|
66
|
259
|
7a0fHHH |
The crystal structure of bovine thrombin in complex with hirudin (c22u/c39u) at 2.7 angstroms resolution |
|
65
|
259
|
7a0eHHH |
The crystal structure of bovine thrombin in complex with hirudin (c6u/c14u) at 1.9 angstroms resolution |
|
9
|
40
|
7a0eLLL |
The crystal structure of bovine thrombin in complex with hirudin (c6u/c14u) at 1.9 angstroms resolution |
|
2
|
28
|
6y02L |
Thrombin in complex with 13k |
|
56
|
257
|
6y02H |
Thrombin in complex with 13k |
|
1
|
28
|
6t8aL |
Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((s)-1-((r)-3-cyclohexyl 2-((phenylmethyl)sulfonamido)propanoyl)pyrrolidine-2-carboxamido)methyl)phosphonate (mi-492) |
|
57
|
258
|
6t52H |
Thrombin in complex with a d-phe-pro-imidazole derivative |
|
9
|
31
|
6tkjL |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 7kev |
|
8
|
36
|
6tkhL |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 7kev |
|
63
|
258
|
6tklH |
Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin |
|
66
|
258
|
6tkhH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 7kev |
|
1
|
28
|
6t52L |
Thrombin in complex with a d-phe-pro-imidazole derivative |
|
7
|
36
|
6tklL |
Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin |
|
61
|
257
|
6tkjH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 7kev |
|
58
|
257
|
6t8aH |
Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((s)-1-((r)-3-cyclohexyl 2-((phenylmethyl)sulfonamido)propanoyl)pyrrolidine-2-carboxamido)methyl)phosphonate (mi-492) |
|
9
|
30
|
6tkiL |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 12.7kev |
|
2
|
30
|
6t3mL |
Thrombin in complex with a d-phe-pro-p-phenol derivative |
|
56
|
258
|
6t3mH |
Thrombin in complex with a d-phe-pro-p-phenol derivative |
|
57
|
258
|
6t57H |
Thrombin in complex with a d-phe-pro-n-amidinopiperidine derivative |
|
3
|
28
|
6t57L |
Thrombin in complex with a d-phe-pro-n-amidinopiperidine derivative |
|
57
|
258
|
6t53H |
Thrombin in complex with a d-phe-pro-p-benzylamine derivative |
|
56
|
257
|
6t54H |
Thrombin in complex with a d-phe-pro-2-bromothiophene derivative |
|
1
|
28
|
6t53L |
Thrombin in complex with a d-phe-pro-p-benzylamine derivative |
|
1
|
29
|
6t55L |
Thrombin in complex with methylbenzylamine |
|
1
|
30
|
6t56L |
Thrombin in complex with benzylamine |
|
57
|
257
|
6t89H |
Thrombin in complex with (s)-n-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2',4'-dimethoxy-[1,1'-biphenyl])-3-sulfonamido)propanoyl)piperazine-1-carboxamide (mi-498) |
|
1
|
28
|
6t89L |
Thrombin in complex with (s)-n-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2',4'-dimethoxy-[1,1'-biphenyl])-3-sulfonamido)propanoyl)piperazine-1-carboxamide (mi-498) |
|
57
|
257
|
6t56H |
Thrombin in complex with benzylamine |
|
67
|
259
|
6tkgH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 12kev |
|
1
|
27
|
6t54L |
Thrombin in complex with a d-phe-pro-2-bromothiophene derivative |
|
62
|
259
|
6tkiH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 12.7kev |
